Friday, August 29, 2025

Bitcoin halving schedule

https://i.redd.it/zarbu8d8m2mf1.png

The Daily Market Flux - Your Complete Market Rundown (08/29/2025)

Market Flux is the new standard in financial news aggregation, we’re committed to providing you with a complete, real-time view of the financial world.

Our platform aggregates and organizes all relevant market news, helping you stay informed, up-to-date, and knowledgeable without spending hours sifting through headlines.

Reinvented to keep you in control, it's where your edge begins with better information. Go from market noise to clarity in seconds with a real-time platform built to redefine how traders and investors digest financial news.

Visit www.marketflux.io

Here is Your Complete Market Rundown (08/29/2025)

Company News

Nvidia Corporation (NVDA)

Performance Overview

1D Change: -3.29%

5D Change: -2.08%

News Volume: 247

Unusual Volume Factor: 1x

Nvidia Stock Slips as Alibaba's New AI Chip Intensifies Competition in Chinese Market

Nvidia's stock faces pressure as Alibaba unveils a new AI chip, potentially challenging Nvidia's dominance in the Chinese market. Despite record earnings, concerns about slowing data center growth and competition weigh on investor sentiment. Analysts remain bullish, with one predicting Nvidia could reach $1 trillion in annual revenue by 2030.

Full coverage of $NVDA on MarketFlux.io

Alibaba Group Holding Limited (BABA)

Performance Overview

1D Change: 12.95%

5D Change: 9.85%

News Volume: 183

Unusual Volume Factor: 9x

Alibaba Surges on AI Advancements and Cloud Growth, Unveils New Chip to Rival Nvidia

Alibaba Group Holding Limited has made significant strides in artificial intelligence (AI) and cloud computing, as revealed in their latest quarterly earnings report and recent developments. Despite missing revenue estimates for the first quarter of 2026, with revenue at 247.65 billion yuan against an expected 253.17 billion yuan, Alibaba's stock surged by 13%, marking its best day since March 2023.

Full coverage of $BABA on MarketFlux.io

Dell Technologies Inc. (DELL)

Performance Overview

1D Change: -9.03%

5D Change: -6.67%

Dell Faces Margin Pressure Despite Strong AI Demand, Sparking Tech Sector Sell-Off

Dell Technologies Inc. has been making headlines with its latest earnings report and market performance. The company reported strong second-quarter results, beating expectations and raising its full-year outlook. However, the stock faced downward pressure due to concerns about profit margins and competition in the AI server market.

Full coverage of $DELL on MarketFlux.io

Caterpillar Inc. (CAT)

Performance Overview

1D Change: -3.66%

5D Change: -3.74%

Caterpillar Warns of Massive $1.8 Billion Tariff Hit, Sparking Market Jitters

Caterpillar Inc. has sent shockwaves through the financial markets by dramatically increasing its estimate of the impact of tariffs on its business for 2025. The heavy machinery giant now projects tariff-related costs could reach as high as $1.8 billion this year, a significant jump from previous forecasts.

Full coverage of $CAT on MarketFlux.io

Geopolitics Events

Thai PM Ousted by Court, Political Uncertainty Looms

Thailand's Constitutional Court dismissed Prime Minister Paetongtarn Shinawatra for an ethics violation, ending her year-long tenure. The ruling, stemming from a leaked phone call with Cambodia's leader, marks another blow to the Shinawatra dynasty.

Trump Pushes for Swift Approval to Fire Fed Governor as Court Hears Case

President Trump seeks immediate approval from a judge to fire Federal Reserve Governor Lisa Cook. Cook has requested an emergency order to block her dismissal.

Trump Strips Kamala Harris of Secret Service Protection, Sparking Political Uproar

President Donald Trump has revoked Kamala Harris' Secret Service protection, as reported by CNN. This unexpected decision is causing a stir in the political arena.

Putin to Engage in Diplomatic Blitz at China Summit, Possible Kim Jong Un Meeting on Agenda

Russian President Putin is set to attend high-level talks in China, meeting with leaders from various nations. The Kremlin confirms Putin will hold bilateral discussions with leaders from India, Turkey, Iran, Pakistan, and Serbia.

U.S. Senate Armed Services Chair Visits Taiwan to Bolster Defense Partnership

U.S. Senator Roger Wicker, Chairman of the Senate Armed Services Committee, has arrived in Taipei.

Trump Administration Slashes Billions in Offshore Wind and Foreign Aid Funding

President Trump's administration takes bold steps to reshape federal spending. The White House cancels $679 million in offshore wind funding, reflecting debates on renewable energy priorities.

Zelensky Sets Deadline for Russia Talks, Seeks Allied Security Guarantees

Ukraine's President Zelensky sets a September 1st deadline for Russia to prepare for talks. He seeks security guarantees from allies and wants Trump to join discussions.

Xi-Modi Summit Spotlights China-India Ties Amid Global Power Shifts

China-India relations take center stage as Xi and Modi prepare to meet at the SCO Summit. The leaders aim to strengthen ties and address issues like rare earth supply.

Macron Vows to Complete Term, Backs PM Amid Political Challenges

French President Emmanuel Macron reaffirms his commitment to serve his full presidential term, despite political challenges. He expresses support for PM Bayrou's confidence motion.

China Holds Key Meetings Amid Economic Concerns and Diplomatic Challenges

China's Politburo held a meeting on August 29. Factory activity is expected to shrink due to soft demand and job concerns. The foreign ministry opposes U.S.-Taiwan exchanges and supports diplomatic solutions for Iran's nuclear issue.

US Appeals Court Strikes Down Trump's Global Tariffs as Illegal

A US appeals court has ruled President Trump's global tariffs illegal. The decision, announced late Friday, was expected but may face further legal challenges.

Trump's Oil Claims Baffle Pakistan as Global Leaders Face Challenges

Pakistan questions Trump's claim of massive oil reserves. South Korea indicts former first lady Kim Keon-hee.

CDC Shakeup: Officials Resign Over Vaccine Policies as New Acting Director Named

RFK Jr.'s push to "fix" the CDC sparks controversy. The Trump administration's vaccine policies face scrutiny, leading to resignations of senior CDC officials. Jim O'Neill, HHS Deputy Secretary, is reportedly selected as the next acting CDC director.

U.S. Blocks Palestinian Officials from Attending UN General Assembly

In a significant diplomatic move, U.S. Secretary of State Marco Rubio is denying and revoking visas for Palestinian officials, including members of the Palestine Liberation Organization and Palestinian Authority.

Iran's President Accuses Israel and US of Seeking to Destroy Iran

Iran's President Pezeshkian declares that Iran does not seek war. However, he accuses Israel and the United States of attempting to divide and destroy Iran.

Stock Markets Events

Markets Pull Back as Strong Month Ends, but Analysts Remain Optimistic

S&P 500 futures decline in premarket trading, with major indices opening lower. Nvidia stock slips as Alibaba develops a new AI chip. Markets brace for potential September weakness after a strong month.

Macro Events

European Economic Data Shows Mixed Results as Inflation Concerns Linger

Spain's CPI remains steady at 2.7% year-on-year, while Italy's GDP growth slows to 0.4%. German states report varied inflation rates, with most showing slight increases. Germany's unemployment rate holds at 6.3%, with a surprising decrease in unemployment claims.

Core Inflation Hits 2.9% as Consumer Spending Remains Robust

July's U.S. PCE inflation data aligns with expectations, showing a 2.6% year-over-year increase. Core PCE rose to 2.9%, the highest since February.

German Retail Sales Slump Unexpectedly, Nordic Economies Show Mixed Results

German retail sales unexpectedly dropped 1.5% in July, surprising economists who predicted no change. Import prices also declined 1.4% year-over-year.

Consumer Sentiment Dips as Inflation Concerns Persist; PCE Index Shows Services Inflation Uptick

The University of Michigan's consumer sentiment survey for August shows a decline to 58.2, below expectations of 58.6. Consumer concerns about high prices persist.

India's Economy Surges 7.8%, Beating Expectations in Latest Quarter

India's economy surpasses expectations, growing 7.8% in the April-June quarter, according to government data. This growth rate outpaces previous forecasts of 6.6-6.7% and marks an increase from the previous quarter's 7.4%.

Canadian Economy Unexpectedly Contracts as Trade War Takes Toll

Canada's economy contracted more than expected in Q2 2025, with GDP shrinking by 1.6% annualized. The decline was primarily attributed to tariffs choking exports and decreased business investment.

Technology Events

Alibaba Unveils Advanced AI Chip, Aims to Bridge Nvidia Gap in China

Alibaba has developed a new AI chip, according to sources cited by the Wall Street Journal. The chip is designed for inference tasks and can handle more AI work than previous versions.

AI Firm DeepSeek Selects Huawei Chips for Small Model Training

DeepSeek, an AI company, has reportedly chosen Huawei chips for training some of its smaller AI models. This decision highlights the growing competition in the AI chip market and potential shifts in technology partnerships.

Crypto Events

Eric Trump Praises Bitcoin Community, Forecasts Million-Dollar Valuation

Eric Trump expresses the Trump family's affection for the Bitcoin community, citing their strong support for his father. He predicts Bitcoin will reach a $1 million valuation.

Ethereum Steals Spotlight as Whale Pivots and Banks Embrace "Wall Street Token"

Ethereum dominates today's crypto news, with bullish signals despite a dip to $4.3K. Analysts see potential for ETH to reach $20,000, backed by institutional interest and ETF momentum.

Healthcare Events

Healthcare Sector Buzzes with Clinical Wins, Patent Victory, and Conference Announcements

BeOne Medicines reports positive results for lymphoma drug, boosting stock. NeoGenomics wins patent case, allowing cancer test marketing. Abbott's TAVI system and Esperion's bempedoic acid receive approvals.

Oil And Gas Events

China Mulls Increased Russian Gas Imports Amid Oil Market Uncertainties

China considers boosting Russian gas imports via the Power of Siberia pipeline, while talks on a second pipeline stall. A Chinese terminal reportedly received LNG from a sanctioned Russian facility.

US Energy Sector Breaks Multiple Records as Production and Demand Surge

US energy production and inventories reached record highs in June. Crude oil output hit an all-time peak, with Gulf production at its highest since October 2023. Natural gas output also set a record.

US Oil Rig Count Rises Amid Overall Decline in Total Rigs

Baker Hughes reports a slight decrease in the US rig count to 536, down 2 from the previous week. Oil rigs increased by 1 to 412, while gas rigs decreased by 3 to 119.

Guyana's Election Heats Up Over Oil Revenue Promises

Guyana's upcoming election is centered on oil revenue distribution. President Ali seeks re-election amid an oil boom, while opposition candidates promise voters a larger share of oil profits from ExxonMobil.

Earnings Events

Alibaba Reports Mixed Q1 Earnings, Plans to Boost AI Cloud Adoption

Alibaba's Q1 2026 earnings report shows mixed results. Revenue of CNY247.652B falls short of estimates, while EPS of CNY2.25 beats expectations.

Remy Cointreau Raises Profit Forecast as US-EU Deal Eases Tariff Concerns

Remy Cointreau, the renowned cognac maker, has revised its profit outlook upwards following a recent US-EU trade deal. The company now anticipates a smaller impact on profits from tariffs than initially projected.

Currencies Events

Indian Rupee Crashes to Record Low Amid US Tariff Concerns

The Indian rupee has plummeted to an all-time low against the US dollar, breaching the 88 mark. This sharp decline is attributed to concerns over the impact of 50% US tariffs on India's economic growth and corporate earnings.

Fixed Income And Interest Rates Events

U.S. Treasury Yields Rise as Stable Inflation Data Keeps Fed Rate Cut Hopes Alive

India's 10-year bond yield sees its largest monthly increase since September 2022, rising 19 bps in August.

Corporate Actions Events

Kraft Heinz Poised to Unveil Major Breakup Plan, Splitting Grocery and Sauces Divisions

Kraft Heinz ($KHC) is on the verge of announcing a major breakup plan, according to the Wall Street Journal.

Permira Explores £2 Billion Takeover of Fund Solutions Provider JTC

Private equity firm Permira is exploring a potential acquisition of JTC, a London-listed provider of fund solutions and corporate services. The deal could be worth around £2 billion.

PepsiCo Boosts Stake in Celsius with $585 Million Investment

PepsiCo is expanding its presence in the energy drink market by increasing its stake in Celsius Holdings. The company is investing $585 million to acquire new convertible preferred stock, raising its ownership to approximately 11%.

Explore More Headlines at www.marketflux.io

Profusa, Inc. Initial Public Offering Released - Here’s What You Should Know

Profusa, Inc. (Nasdaq: PFSA)
Investor Summary Report – August 29, 2025

Company Overview
Profusa, Inc. is a clinical-stage digital health and medical technology company, focused on the development of bioengineered sensors for real-time monitoring of biochemical markers in the body. The company’s core products are the Lumee™ Oxygen Platform (CE marked in the EU) and Lumee™ Glucose Platform (investigational CGM system). Profusa recently completed a business combination with NorthView Acquisition Corporation and has also implemented a Bitcoin treasury strategy.

Key Financial Metrics

Revenue:
- For the year ended December 31, 2024: $100,000 (government grants)
- For the six months ended June 30, 2025: $0
- No commercial sales reported; revenue is currently derived solely from government grants (NIH, DARPA).
Net Loss:
- FY 2024: $(9.23) million
- FY 2023: $(10.28) million
- 6M ended June 30, 2025: $(5.06) million
- 6M ended June 30, 2024: $(4.48) million
- Net loss per share FY 2024: $(1.65);
  6M 2025: $(0.90)
Operating Expenses:
- FY 2024: $4.60 million
- 6M ended June 30, 2025: $2.43 million
R&D and G&A Breakdown (6M 2025):
- Research & Development: $827,000
- General & Administrative: $1.6 million
Cash and Liquidity:
- Cash as of June 30, 2025: $44,000
- Cash as of December 31, 2024: $191,000
- Net cash used in operations (6M 2025): $(1.13) million
- Profusa expects to rely on additional capital raises to fund operations and product development.
Debt and Liabilities (as of June 30, 2025):
- Total current liabilities: $63.48 million
- Total convertible debt outstanding: $49.97 million
- Promissory notes: $940,000
- PPP loan: $1.38 million (defaulted due to nonpayment of minimum required amounts)
- Tasly convertible debt (related party): $2.54 million
Equity Position:
- Accumulated deficit as of June 30, 2025: $(130.0) million
- Post-business combination, outstanding shares is expected to be ~69.2 million; after full impact of PIPE/ELOC/Note conversions, up to 258.3 million.

Key Risks

Substantial Doubt about Going Concern
- Auditors and management express substantial doubt about Profusa’s ability to continue as a going concern. The company is reliant on future financing to fund operations. As of June 30, 2025, available cash is minimal, and operating losses and negative cash flow persist.
No Commercial Product Revenues
- All revenues to date are from government grants. Commercialization of Lumee Oxygen is at an early stage (EU only); Lumee Glucose has not received FDA or EU approval.
Heavy Debt Load
- The company carries significant short-term debt, including $49.97 million in convertible notes and $27.9 million in senior notes (much due within the current period). Much of this must be repaid or converted to equity in connection with financing events or joint venture arrangements.
Execution and Regulatory Risks
- No assurance of FDA 510(k) or PMA approval for U.S. commercialization.
- Delays or failures in clinical trials and regulatory submissions could halt commercialization efforts. For example, execution of ongoing pivotal studies for Lumee Oxygen in the U.S. may be impacted by site enrollment and regulatory feedback.
Single-Product Concentration
- Near-term revenues depend almost entirely on the successful commercialization of the Lumee Oxygen Platform.
Reliance on Clinical Partners and Suppliers
- The company is dependent on third-party suppliers, contract manufacturers, and CROs. Supply disruptions or third-party failures could significantly impact timelines and product quality.
Competitive Landscape
- Profusa faces large, established competitors in both the oxygen monitoring (e.g., Siemens Healthineers) and glucose monitoring space (Dexcom, Abbott, Medtronic). Larger competitors have greater resources, market presence, and regulatory experience.
Material Weaknesses in Internal Controls
- The company has identified deficiencies in internal controls over financial reporting and has not engaged an independent auditor for these controls.
Significant Dilution Risk
- Investor dilution is expected from PIPE and ELOC transactions and conversion of large tranches of debt. The registration statement covers up to 222,222,222 shares.
Bitcoin Treasury Strategy
- The company's intentions to hold and buy Bitcoin expose it to significant market, regulatory, counterparty, and liquidity risk. Bitcoin is highly volatile, and reclassification as a security could lead to regulatory complications.

Management Discussion & Analysis

Profusa’s core strategy is to gain traction in Europe with its CE-marked Lumee Oxygen product, pursue FDA approval, and develop and eventually commercialize the Lumee Glucose CGM platform.
The company reports no serious adverse events in clinical studies to date for either oxygen or glucose sensors.
Management notes that COVID-19, inflationary pressures, and geopolitical instability (e.g., Russia/Ukraine crisis) continue to challenge supply chains and the company’s ability to operate efficiently.
Ongoing expenditures are focused on R&D, regulatory compliance, and preparation for larger-scale commercialization pending regulatory approvals.
Profusa has received significant funding via the PIPE transaction and expects to raise further funds through the committed equity facility and additional note conversions.
The company is also exploring partnerships for "data as a service" business models alongside device launches.

Ownership and Corporate Governance

The board consists of five directors, split into classes, with Ben Hwang (Chairman and CEO) and Fred Knechtel (CFO) as key executives.
Largest shareholders post-combination include NorthView Sponsor I, LLC (24%), Fred Knechtel (24.9%), Jack Stover (24%), Ascent Partners Fund LLC (9.99%), and BC hSensor Limited (5%).

Conclusion & Investor Considerations

Investors should note that Profusa remains an early-stage, pre-revenue medtech company facing significant going concern risks, high debt, execution uncertainty, and future dilution. Success is highly dependent on regulatory milestones and execution of its commercialization plan. The innovative nature of its biosensor technology is balanced by heavy competition, and the bitcoin treasury strategy adds novel, non-traditional risk to the company’s profile. This investment is suitable only for those with high risk tolerance and a long-term horizon.

Visit Publicview AI to search and analyze millions of SEC filings using AI.